Wound Imaging Device Market (2026 - 2033)

Wound Imaging Device Market Summary

The global wound imaging device market size was valued at USD 288.2 million in 2025 and is projected to grow from USD 330.2 million in 2026 to USD 953.7 million by 2033, at a CAGR of 16.4% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 47.1% in 2025. The growth of the wound imaging device industry is primarily driven by the rising prevalence of chronic wounds, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers, along with the increasing global burden of diabetes and an aging population. 

Growing adoption of AI-enabled wound assessment, digital wound documentation, and telemedicine solutions is further accelerating demand by enabling accurate wound measurement, early detection of complications, and improved clinical decision-making across healthcare settings. The increasing prevalence of chronic wounds, particularly diabetic foot ulcers (DFUs), pressure ulcers, and venous leg ulcers, is a major driver of the wound imaging device market.

As the global diabetic population continues to grow, healthcare providers are adopting wound imaging technologies to enable accurate wound measurement, monitor healing progression, and support early detection of complications. Studies indicate that people with diabetes have a 19-34% lifetime risk of developing a diabetic foot ulcer, highlighting the need for advanced wound assessment solutions.

The increasing adoption of AI-powered wound assessment technologies is a key driver of the wound imaging device market, enabling automated wound measurement, tissue classification, healing prediction, and early detection of complications with greater accuracy than conventional assessment methods. AI-based image analysis also standardizes wound documentation, reduces clinician variability, and supports remote monitoring through telemedicine, improving clinical outcomes and workflow efficiency. For instance, Swift Medical's Swift Skin & Wound platform leverages AI and a database of more than 32 million wound images to provide automated wound assessment, tissue analytics, and clinical decision support. The platform has demonstrated improved clinical efficiency, including 79% faster wound assessments and 15% fewer wound-related hospitalizations, highlighting the growing adoption of AI in wound care.

The rising prevalence of diabetic foot ulcers (DFUs) is a major driver of the wound imaging device market, as these chronic wounds require regular assessment to monitor healing and detect complications early. Wound imaging devices enable accurate wound measurement, tissue analysis, and documentation, helping clinicians optimize treatment decisions, reduce the risk of infection and amputation, and improve patient outcomes.

Similarly, the increasing prevalence of venous leg ulcers (VLUs) is driving the demand for wound imaging devices, as these chronic wounds require frequent monitoring to assess healing progression and guide treatment decisions. Advanced wound imaging technologies provide accurate wound measurement, tissue visualization, and digital documentation, enabling clinicians to optimize compression therapy, detect complications early, and improve overall patient outcomes. 

Market Dynamics

The wound imaging device market is experiencing strong growth, driven by the rising prevalence of chronic wounds, increasing incidence of diabetes, and growing adoption of AI-powered digital wound assessment technologies. Advancements in 3D, fluorescence, and hyperspectral imaging, as well as cloud-based analytics, are improving diagnostic accuracy and treatment monitoring across healthcare settings. However, high device costs, reimbursement limitations, and regulatory compliance requirements may restrain market growth, while expanding telemedicine, home healthcare, and smartphone-based wound-imaging solutions offer significant growth opportunities. 

Market Concentration & Characteristics

The wound imaging device market is characterized by high innovation, driven by advancements in AI-powered image analysis, multimodal imaging, smartphone-based wound assessment, and cloud-enabled clinical workflows. Manufacturers are continuously enhancing imaging accuracy, bacterial detection, thermal assessment, and remote monitoring capabilities to improve clinical decision-making. For instance, in April 2025, MolecuLight launched the Thermal Imaging Module for its MolecuLight DX platform, integrating thermal imaging with fluorescence imaging and digital wound measurement in a single handheld device to provide comprehensive point-of-care wound assessment.

“MolecuLight continues to push the boundaries of diagnostic imaging in wound care, and this launch represents a significant leap forward,” said Anil Amlani, CEO of MolecuLight. “For the first time, clinicians can access critical insights from three essential assessment modalities - precise digital wound measurement, our validated bacterial fluorescence imaging, and informative thermal imaging - all seamlessly integrated within a single, handheld device. This powerful, multimodal capability provides a truly comprehensive view of the wound environment right at the point-of-care, empowering clinicians with unparalleled insights for more effective, data-driven treatment decisions and enhanced monitoring of healing progress.”

The wound imaging device industry is witnessing a moderate level of mergers and acquisitions, with companies pursuing strategic acquisitions and partnerships to strengthen their digital health, AI, and wound care capabilities. M&A activity is primarily focused on expanding product portfolios, integrating advanced imaging technologies with software platforms, and enhancing geographic reach. These collaborations are accelerating innovation, improving end-to-end wound management solutions, and increasing market competitiveness.

Regulatory frameworks have a high impact on the market, as manufacturers must comply with stringent safety, performance, cybersecurity, and clinical validation requirements before commercialization. Regulatory approvals from agencies such as the U.S. FDA, European MDR, and other national authorities are driving the development of reliable, AI-enabled wound imaging systems while ensuring patient safety and data security. These regulations also encourage interoperability with electronic health records (EHRs) and support broader clinical adoption of digital wound assessment technologies. For instance, in January 2026, MolecuLight announced that its MolecuLightDX wound measurement technology was qualified by the U.S. FDA as a Medical Device Development Tool (MDDT). This qualification enables the device’s quantitative wound measurement function to generate FDA-accepted data for clinical investigations and supports its use as a validated tool in the evaluation and regulatory development of new wound care products, strengthening confidence in digital wound imaging technologies.

“The FDA’s qualification of MolecuLightDX as an MDDT reflects the strength of our clinical evidence and the agency’s confidence in the accuracy and reproducibility of our wound measurement technology,” said Anil Amlani, Chief Executive Officer of MolecuLight. “This designation enables researchers and sponsors to use MolecuLightDX as a standardized, trusted measurement tool in wound healing studies, accelerating innovation and improving patient outcomes.”

The wound imaging device market exhibits moderate to high end-use concentration, with hospitals and specialized wound care centers accounting for the largest share due to their high patient volumes and adoption of advanced wound assessment technologies. However, the increasing use of portable imaging devices, AI-powered software, and telemedicine platforms is expanding adoption across outpatient clinics, home healthcare, and long-term care facilities, gradually diversifying the end-user landscape.

Analyst Perspective

The wound imaging device market is expected to witness strong long-term growth, driven by the increasing prevalence of chronic wounds, rapid adoption of AI-powered wound assessment, and expanding use of digital health technologies. The transition from subjective visual wound evaluation to objective, image-based assessment is improving clinical accuracy, treatment planning, and patient outcomes across hospitals, wound care clinics, and home healthcare settings.

The integration of artificial intelligence, cloud connectivity, electronic health records (EHRs), and remote patient monitoring will be a key differentiator among market participants. Companies that focus on developing portable, cost-effective, and interoperable imaging solutions while expanding regulatory approvals and clinical evidence are expected to strengthen their competitive position and capture significant market share during the forecast period.

Product Type Insights

The dedicated handheld & portable devices segment dominated the wound imaging device market in 2025, owing to their portability, ease of use, and ability to provide rapid, point-of-care wound assessment across hospitals, outpatient clinics, and home healthcare settings. These devices offer accurate wound measurement, high-resolution imaging, and real-time documentation while improving clinical workflow and reducing assessment variability. Their increasing integration with AI-powered analytics and cloud-based platforms has further strengthened their adoption for chronic wound monitoring and treatment planning.

The mobile app & software solutions segment is expected to register the fastest growth during the forecast period, driven by the increasing adoption of smartphone-based wound assessment, telemedicine, and remote patient monitoring. AI-powered mobile applications enable real-time wound measurement, automated documentation, and cloud-based data sharing, improving clinical decision-making and care coordination. Their lower implementation cost, ease of deployment, and seamless integration with electronic health records (EHRs) are further accelerating adoption across hospitals, home healthcare, and outpatient settings.

Technology/Modality Insights

The visible light imaging (2D/color) segment dominated the wound imaging device industry in 2025, owing to its widespread adoption for routine wound documentation, accurate wound measurement, and cost-effective clinical assessment. The technology is easy to use, integrates seamlessly with smartphones and electronic health records (EHRs), and supports consistent monitoring of wound healing over time. Its broad availability across hospitals, wound care clinics, and home healthcare settings has further strengthened its leading market position.

The near-infrared (NIR) & hyperspectral imaging segment is expected to witness the fastest growth during the forecast period, driven by its ability to provide non-invasive assessment of tissue oxygenation, perfusion, and wound viability before visible clinical changes occur. These advanced imaging technologies enable early detection of infection and ischemia, supporting more precise treatment decisions and improved healing outcomes. Increasing integration with AI-based image analysis and growing adoption in chronic wound management and research are further accelerating segment growth.

Wound Type Insights

The chronic wounds segment dominated the wound imaging device market in 2025, driven by the rising prevalence of diabetic foot ulcers, pressure ulcers, and venous leg ulcers that require continuous monitoring and long-term management. Wound imaging devices enable accurate measurement, standardized documentation, and timely assessment of healing progression, improving clinical decision-making. The increasing burden of diabetes, an aging population, and growing adoption of digital wound care solutions further supported the segment’s market dominance.

The acute & other wounds segment is expected to register the fastest growth during the forecast period, driven by the increasing number of surgical procedures, traumatic injuries, burns, and emergency wound cases worldwide. Growing adoption of digital wound imaging for rapid assessment, infection monitoring, and treatment planning in emergency departments and surgical settings is accelerating demand. In addition, the expanding use of portable, AI-enabled wound imaging devices in hospitals and ambulatory care centers is expected to further support segment growth.

End Use Insights

The hospitals segment dominated the wound imaging device industry in 2025, driven by the high volume of patients with chronic wounds, surgical wounds, burns, and traumatic injuries requiring advanced wound assessment. Hospitals have well-established infrastructure and greater access to digital imaging technologies, enabling accurate wound documentation, monitoring, and multidisciplinary care. The increasing adoption of AI-enabled wound imaging systems integrated with electronic health records (EHRs) further strengthened the segment’s market leadership.

The specialized wound care clinics segment is expected to register the fastest growth during the forecast period, driven by the increasing number of patients with chronic and complex wounds requiring dedicated multidisciplinary care. These clinics are rapidly adopting advanced wound imaging devices to improve diagnostic accuracy, monitor healing progression, and optimize treatment outcomes. Growing hospital referrals, rising demand for outpatient wound management, and greater integration of AI-enabled imaging technologies are further accelerating segment growth.

Regional Insights

The North America wound imaging device market accounted for a significant share of the global market, driven by the high prevalence of chronic wounds, diabetic foot ulcers, and pressure injuries, as well as the widespread adoption of advanced digital wound care technologies. The region also benefits from well-established healthcare infrastructure, favorable reimbursement for wound management services, increasing integration of AI-enabled imaging solutions, and the strong presence of leading medical device manufacturers, all of which support continued market growth.

U.S. Wound Imaging Device Market Trends

The U.S. wound imaging device industry accounts for the largest share of North America, driven by the high prevalence of chronic wounds, the increasing incidence of diabetes and obesity, and strong adoption of digital wound assessment technologies. The country's advanced healthcare infrastructure, favorable reimbursement landscape, widespread implementation of electronic health records (EHRs), and early adoption of AI-enabled wound imaging solutions continue to support market growth across hospitals, wound care centers, and home healthcare settings.

Europe Wound Imaging Device Market Trends

The Europe wound imaging device industry holds a substantial share of the global market, driven by the rising prevalence of chronic wounds, an aging population, and increasing adoption of advanced digital wound management solutions. Strong government support for digital healthcare, expanding telemedicine services, and the presence of well-established wound care centers and leading medical device manufacturers are further accelerating the adoption of AI-enabled wound imaging technologies across the region.

The U.K. wound imaging device market is experiencing steady growth, driven by the increasing burden of chronic wounds, an aging population, and the rising prevalence of diabetes. Growing adoption of digital wound assessment technologies across the National Health Service (NHS), along with increasing investment in AI-enabled wound management and community-based care, is supporting improved clinical outcomes and driving market expansion.

The wound imaging device market in France is witnessing significant growth, driven by the increasing prevalence of chronic wounds, a rapidly aging population, and the growing burden of diabetes. Rising investments in digital health, expanding adoption of AI-assisted wound assessment technologies, and strong government support for modernizing healthcare services are accelerating the use of wound imaging devices across hospitals and specialized wound care clinics.

Asia Pacific Wound Imaging Device Market Trends

The Asia Pacific wound imaging device industry is expected to grow at the fastest CAGR during the forecast period, driven by the rising prevalence of diabetes, the increasing incidence of chronic and traumatic wounds, and the expanding healthcare infrastructure across emerging economies. Growing investments in digital healthcare, increasing adoption of AI-enabled wound assessment technologies, and greater awareness of advanced wound management are further accelerating market growth throughout the region.

The Japan wound imaging device market is growing significantly, driven by the country's rapidly aging population, rising prevalence of diabetes and chronic wounds, and strong emphasis on early diagnosis and advanced wound management. Increasing adoption of AI-enabled medical imaging, supportive healthcare infrastructure, and ongoing investments in digital health technologies are further accelerating the use of wound imaging devices across hospitals and long-term care facilities.

Latin America Wound Imaging Device Market Trends

The Latin America wound imaging device industry is experiencing steady growth, driven by the rising prevalence of diabetes, chronic wounds, and traumatic injuries, as well as improved access to healthcare services. Rising investments in healthcare infrastructure, growing awareness of advanced wound management, and the gradual adoption of digital and AI-enabled wound assessment technologies are supporting market expansion across the region.

MEA Wound Imaging Device Market Trends

The MEA wound imaging device industry is witnessing gradual growth, driven by the rising prevalence of diabetes, chronic wounds, burns, and traumatic injuries across the region. Increasing investments in healthcare infrastructure, expanding adoption of digital health technologies, and growing government initiatives to modernize healthcare systems are supporting the uptake of advanced wound imaging devices, particularly in the Gulf countries.

Key Wound Imaging Device Company Insights

The wound imaging device market is moderately consolidated, with key players focusing on AI-powered wound assessment, cloud-based imaging platforms, and integration with electronic health records to strengthen their competitive position. Companies are expanding their market presence through product innovation, regulatory approvals, strategic partnerships, and geographic expansion, while increasing demand for digital wound management solutions intensifies competition and drives market share gains.

Key Wound Imaging Device Companies

The following key companies have been profiled for this study of the wound imaging device market.

• MolecuLight

• Spectral AI, Inc.

• Swift Medical Inc.

• eKare, Inc.

• Net Health

• Kent Imaging Inc

• WoundVision

• Adiuvo Diagnostics Private Limited

• ARANZ Medical Limited

•  WoundZoom

• Healthy.io Ltd

• imito AG 

Competitive Benchmarking

Recent Developments

• In January 2026, MolecuLight announced that the wound measurement functionality of its MolecuLightDX device had been qualified by the U.S. Food and Drug Administration as a Medical Device Development Tool (MDDT). This qualification enables technology to generate scientifically validated, FDA-accepted wound measurement data for use in medical device clinical investigations, supporting the development and evaluation of new wound care technologies.

• In April 2025, MolecuLight launched a Thermal Imaging Module for its MolecuLightDX fluorescence imaging platform. The new clip-on module enables clinicians to capture thermal images alongside fluorescence images for bacterial detection and standard wound images for digital measurement, providing a comprehensive point-of-care wound assessment solution that enhances clinical decision-making and wound management.

Wound Imaging Device Market Report Scope

Global Wound Imaging Device Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global wound imaging device market report based on product type, technology / modality, wound type, end use, and region:

• Product Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Dedicated Handheld & Portable Devices

  • Mobile App & Software Solutions

  • Cart-based & Desktop Systems

• Technology / Modality Outlook (Revenue, USD Million, 2021 - 2033)

  • Visible Light Imaging (2D/Color)

  • Structured Light / 3D Volumetric Imaging

  • Fluorescence Imaging

  • Near-Infrared (NIR) & Hyperspectral Imaging

  • Thermal Imaging

• Wound Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Chronic Wounds

    • Diabetic Foot Ulcers (DFUs)

    • Pressure Ulcers (PUs)

    • Venous Leg Ulcers (VLUs)

  • Acute & Other Wounds

    • Surgical Wounds

      • Clean & Clean-Contaminated Wounds (Class I/II)

      • Contaminated & Dirty Wounds (Class III/IV)

    • Traumatic Wounds

    • Burns

• End Use Outlook (Revenue, USD Million; 2021 - 2033)

  • Hospitals

  • Specialized Wound Care Clinics

  • Long-Term Care Facilities (Nursing Homes/Skilled Nursing)

  • Home Healthcare Settings

  • Research & Military Healthcare Facilities

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Sweden

    • Denmark

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The wound imaging device market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each wound imaging device segment quantified using the revenue-capture definitions in the table below.

Segment Definition

Estimation Model

Delivered Customizations

This report has been delivered with the following In-depth customizations